ACTRN12616001657415招募中1 期
A Phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics (PK) of escalating single dose of brincidofovir administered intravenously in healthy adult subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •non-child bearing potential
- •willing and able to provide written informed consent
- •non-tobacco/non-nicotine user in the past 6 months
- •body weight no greater than 50kg
- •BMI from 18-32 kg/m
- •no significant medical history
- •males cannot donate sperm during participation
排除标准
- •child bearing potential
- •investigational drug or clinical study in the past 30 days
- •had any infection within the past 2 weeks
- •history of history chronic liver disease
研究者
相似试验
招募中
1 期
Phase 1 study of BRB-002 in healthy male volunteersCardiovascularCardiovascular - Other cardiovascular diseasesACTRN12624000405516Bitterroot Australia Pty Ltd48
已完成
不适用
A Phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose study to evaluate the safety and tolerability of GX-I7 in HPV-infected female volunteersDiseases of The genitoruinary systemKCT0002389Genexine32
已完成
1 期
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm Study of the Safety, Tolerability and Pharmacokinetics of Oral BTD-001 in Healthy VolunteersCognitive impairmentNeurological - Neurodegenerative diseasesACTRN12613000919718Balance Therapeutics Pty Limited30
已完成
不适用
A Phase 1, randomized, double-blind, placebo-controlled, single ascending dose study to assess the safety, tolerability, pharmacokinetics andDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0002390Genexine50
已完成
不适用
A phase 1, randomized, double-blind, placebo-controlled, multiple dose platform study investigating the immunopharmacology of EDP1815 and EDP2939NL-OMON51644Evelo Biosciences72